There are two types of CGRP medications: monoclonal antibodies and small-molecule antagonists (gepants). Both can be used to limit how often migraines occur, and how severe and how long the ...

The Clinical Guidelines Committee of the American College of Physicians (ACP) has released a new clinical guideline on the ...

CGRP antagonists, sometimes referred to as “gepants,” prevent CGRP from binding to receptors in various cell types in the brain. atogepant (Qulipta) rimegepant (Nurtec ODT) ubrogepant (Ubrelvy ...

With historical data showing migraine to be underdiagnosed and undertreated, new guidance from the American College of ...

Pfizer has agreed to pay $60 million to resolve allegations brought by the US government that its Biohaven Pharma subsidiary made improper payments to physicians to boost sales of its migraine drug ...

While both gepants and triptans bind to the blood vessel ... There are only two other such CGRP receptor antagonists: AbbVie’s Ubrogepant and Atogepant. At the start of February this year ...

Decreased tear levels of CGRP and SP correlate with dry eye disease severity and symptoms. Study involved 12 healthy volunteers and 16 DED patients, highlighting significant neuropeptide level ...